NUWELLIS, INC. Impairment of Long-Lived Assets Held-for-use
NUWELLIS, INC. (NUWE) reported Impairment of Long-Lived Assets Held-for-use of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-11.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ImpairmentOfLongLivedAssetsHeldForUse · last filed 2026-03-11
- NUWELLIS, INC. impairment of long-lived assets held-for-use for fiscal 2025 was $0.00.
- NUWELLIS, INC. impairment of long-lived assets held-for-use for fiscal 2024 was $0.00.
- NUWELLIS, INC. impairment of long-lived assets held-for-use for fiscal 2023 was $0.00.
- NUWELLIS, INC. impairment of long-lived assets held-for-use for fiscal 2022 was $0.00.
| Period end | Impairment of Long-Lived Assets Held-for-use 12 month |
|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-03-11 |
| 2024-12-31 | $0.00 10-K · filed 2026-03-11 |
| 2023-12-31 | $0.00 10-K · filed 2025-03-11 |
| 2022-12-31 | $0.00 10-K · filed 2024-03-11 |
| 2021-12-31 | $0.00 10-K · filed 2023-03-03 |
| 2020-12-31 | $0.00 10-K · filed 2022-03-03 |
| 2019-12-31 | $0.00 10-K · filed 2021-03-25 |
| 2018-12-31 | $0.00 10-K · filed 2020-03-05 |
| 2017-12-31 | $0.00 10-K · filed 2019-02-21 |
| 2016-12-31 | $0.00 10-K · filed 2018-03-22 |
| 2015-12-31 | $0.00 10-K · filed 2017-03-08 |
| 2014-12-31 | $0.00 10-K · filed 2016-03-15 |
| 2013-12-31 | $0.00 10-K · filed 2016-03-15 |
| 2012-12-31 | $0.00 10-K · filed 2014-03-14 |
| 2011-12-31 | $0.00 10-K · filed 2013-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ENDRA Life Sciences Inc. (NDRA) | United States | $0.009B | |
| IRIDEX CORP (IRIX) | United States | $0.011B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B |